Your browser doesn't support javascript.
loading
Pharmacokinetic incompatibility of the Huanglian-Gancao herb pair.
Zhang, Ji-Quan; Wang, Rui; Zhou, Ting; Zhao, Qing; Zhao, Chun-Cao; Ma, Bing-Liang.
Afiliação
  • Zhang JQ; Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Wang R; Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Zhou T; Department of Pharmacology, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Cai Lun Road 1200, Shanghai, 201203, China.
  • Zhao Q; Department of Pharmacology, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Cai Lun Road 1200, Shanghai, 201203, China.
  • Zhao CC; Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Ma BL; Department of Pharmacology, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Cai Lun Road 1200, Shanghai, 201203, China. bingliang.ma@hotmail.com.
BMC Complement Med Ther ; 20(1): 61, 2020 Feb 22.
Article em En | MEDLINE | ID: mdl-32087732
ABSTRACT

BACKGROUND:

Pharmacokinetic interaction is one of the most important indices for the evaluation of the compatibility of herbal medicines. Both Gancao (Glycyrrhizae Radix et Rhizoma) and Huanglian (Coptidis Rhizoma) are commonly used traditional Chinese medicines (TCMs). In this study, the influence of Gancao on the pharmacokinetics of Huanglian was systematically studied by using berberine as a pharmacokinetic marker.

METHODS:

Extracts of the herbal pieces of Huanglian and the herb pair (Huanglian plus Gancao) were prepared with boiling water. The concentration of berberine in the samples was analyzed using liquid chromatography-mass spectrometry. The total amounts of berberine in all extract samples were compared. Comparative pharmacokinetic studies of Huanglian and the herb pair were conducted in ICR mice. In vitro berberine absorption and efflux were studied using mice gut sacs. The equilibrium solubility of berberine in the extracts was determined. The in vitro dissolution of berberine was comparatively studied using a rotating basket method.

RESULTS:

Gancao significantly reduced berberine exposure in the portal circulation (425.8 ng·h/mL vs. 270.4 ng·h/mL) and the liver (29,500.8 ng·h/mL vs. 15,422.4 ng·h/mL) of the mice. In addition, Gancao decreased the peak concentration (Cmax) of berberine in the portal circulation (104.3 ng·h/mL vs. 76.5 ng·h/mL) and liver (4926.1 ng·h/mL vs. 2642.8 ng·h/mL) of mice. Significant influences of Gancao on the amount of berberine extracted (32% reduction), the solubility of berberine (34.7% compared with the control group), and dissolution (88.7% vs. 66.1% at 15 min in acid buffer and 68% vs. 51.8% at 15 min in phosphate buffer) were also revealed. Comparative pharmacokinetic studies in ICR mice indicated that the formation of sediment was unfavorable in terms of berberine absorption (345.3 ng·h/mL vs. 119.8 ng·h/mL).

CONCLUSIONS:

Gancao was able to reduce intestinal absorption and in vivo exposure of berberine in Huanglian via the formation of sediment, which caused reductions in the extracted amount, solubility, and dissolution of berberine.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Plantas_medicinales Assunto principal: Berberina / Medicamentos de Ervas Chinesas / Extratos Vegetais Tipo de estudo: Diagnostic_studies Idioma: En Revista: BMC Complement Med Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Plantas_medicinales Assunto principal: Berberina / Medicamentos de Ervas Chinesas / Extratos Vegetais Tipo de estudo: Diagnostic_studies Idioma: En Revista: BMC Complement Med Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China